Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model
Open Access
- 25 April 2023
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 76 (8) , 481-488
Abstract
COVID-19, caused by SARS-CoV-2 infection, is currently among the most important public health concerns worldwide. Although several effective vaccines have been developed, there is an urgent clinical need for effective pharmaceutical treatments for treatment of COVID-19. Ivermectin, a chemical derivative of avermectin produced by Streptomyces avermitilis, is a macrocyclic lactone with antiparasitic activity. Recent studies have shown that ivermectin inhibits SARS-CoV-2 replication in vitro. In the present study, we investigated the in vivo effects of ivermectin in a hamster model of SARS-CoV-2 infection. The results of the present study demonstrate oral administration of ivermectin prior to SARS-CoV-2 infection in hamsters was associated with decreased weight loss and pulmonary inflammation. In addition, the administration of ivermectin reduced pulmonary viral titers and mRNA expression level of pro-inflammatory cytokines associated with severe COVID-19 disease. The administration of ivermectin rapidly induced the production of virus-specific neutralizing antibodies in the late stage of viral infection. Zinc concentrations leading to immune quiescence were also significantly higher in the lungs of ivermectin-treated hamsters compared to controls. These results indicate that ivermectin may have efficacy in reducing the development and severity of COVID-19 by affecting host immunity in a hamster model of SARS-CoV-2 infection.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancerOncotarget, 2017
- Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b -deficient miceProceedings of the National Academy of Sciences, 2015
- The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolismNature Communications, 2013
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virusBiochemical Journal, 2012
- Ivermectin, 'Wonder drug' from Japan: the human use perspectiveProceedings of the Japan Academy, Series B, 2011
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell CulturePLOS Pathogens, 2010
- Calcium signaling in immune cellsNature Immunology, 2008
- Roles of Zinc and Zinc Signaling in Immunity: Zinc as an Intracellular Signaling Molecule2008
- Toll-like receptor–mediated regulation of zinc homeostasis influences dendritic cell functionNature Immunology, 2006
- The life and times of ivermectin — a success storyNature Reviews Microbiology, 2004